Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-21

Clinical Trial Update: Pharmacologic Response and Safety of Inhaled Insulin in Type 1 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on the pharmacologic response and safety of inhaled insulin in individuals with Type 1 Diabetes, based on Phase 1 and Phase 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inhaled insulin (insulin)

Snippet

Sponsor: Dance Biopharm Inc. | Conditions: Type 1 Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED